caus
agent
aid
major
global
health
crisi
claim
million
live
hiv
envelop
protein
env
mediat
viral
entri
target
cell
mainli
cell
macrophag
env
interact
host
cell
factor
chemokin
coreceptor
howev
hiv
attach
cell
independ
coreceptor
attach
modul
viral
infect
suscept
neutral
antibodi
instanc
bind
hiv
lectin
dcsign
immatur
monocytederiv
dendrit
cell
increas
viral
infect
adjac
target
cell
might
clear
env
bound
neutral
antibodi
similarli
erythrocyt
neg
report
select
bind
infecti
hiv
thu
interact
hiv
receptorneg
nonsuscept
cell
alter
viral
infect
recognit
immun
system
might
thu
modul
viral
spread
patient
platelet
essenti
haemostasi
also
contribut
fundament
biolog
process
includ
inflamm
defenc
invad
pathogen
instanc
platelet
select
kill
erythrocyt
harbour
malaria
parasit
plasmodium
falciparum
protect
spread
parasit
sever
disjoint
observ
suggest
platelet
might
also
play
role
hiv
spread
thu
thrombocytopenia
low
platelet
count
frequent
complic
infect
afflict
infect
individu
addit
platelet
count
found
associ
viral
load
diseas
progress
indic
platelet
might
modul
viral
spread
patient
final
platelet
shown
bind
hiv
cell
cultur
infect
patient
viral
captur
activ
trace
calciumdepend
ctype
lectin
dcsign
detect
surfac
platelet
howev
present
unclear
hiv
captur
platelet
impact
viral
infect
platelet
activ
upon
exposur
eg
compon
vascular
connect
tissu
activ
induc
morpholog
chang
releas
effector
molecul
store
within
platelet
granul
includ
recent
identifi
inhibitor
evid
platelet
hiv
infect
individu
show
sign
activ
consequ
activ
platelet
function
hiv
interact
unclear
also
larg
unknown
platelet
activ
context
hiv
infect
certain
adenovirus
activ
platelet
via
direct
interact
hiv
might
scenario
experiment
test
provid
evid
platelet
inhibit
host
cell
entri
activationinduc
releas
abund
compon
platelet
result
suggest
platelet
might
constitut
far
unappreci
innat
barrier
transmiss
spread
previous
shown
ctype
lectin
dcsign
facilit
bind
platelet
bound
virus
infecti
adjac
cell
goal
present
studi
determin
platelet
modul
spread
cocultur
cell
addit
sought
reveal
potenti
impact
platelet
infect
depend
platelet
activ
statu
order
obtain
differenti
activ
platelet
either
prevent
platelet
activ
treatment
prostaglandin
activ
platelet
exposur
thrombin
receptor
agonist
peptid
trap
left
platelet
untreat
analysi
express
platelet
activ
marker
confirm
treatment
trap
effect
thu
platelet
expos
trap
express
high
level
activ
platelet
aplt
express
platelet
treat
close
background
rest
platelet
rplt
figur
untreat
platelet
intermedi
phenotyp
untreat
platelet
plt
figur
addit
investig
untreat
platelet
express
ctype
lectin
known
bind
hiv
env
protein
result
demonstr
express
low
level
dcsign
agreement
previou
studi
mannos
receptor
mr
figur
ctype
lectin
previous
shown
promot
captur
transinfect
macrophag
contrast
lsectin
ctype
lectin
captur
recombin
env
infecti
detect
platelet
figur
although
rule
low
level
lectin
express
remain
undetect
due
limit
assay
sensit
analysi
ctype
lectin
express
activ
platelet
yield
similar
result
data
shown
indic
activ
modul
ctype
lectin
express
analysi
plateletmedi
transinfect
previous
expos
untreat
platelet
rel
high
amount
ng
rang
antigen
remov
unbound
viru
incub
period
cocultiv
platelet
target
cell
protocol
suitabl
detect
captur
might
poorli
reflect
interindividu
transmiss
gener
low
amount
viru
transmit
cell
free
virion
present
order
better
mirror
introduct
blood
stream
upon
sexual
parenter
transmiss
appli
rel
low
amount
viru
pg
rang
antigen
cocultur
platelet
peripher
blood
mononuclear
cell
pbmc
omit
wash
step
therefor
design
close
cultur
system
quantifi
viral
spread
six
day
post
infect
condit
observ
mark
inhibit
spread
presenc
untreat
platelet
figur
examin
inhibitori
effect
employ
cell
allow
conveni
quantif
infect
addit
untreat
platelet
inhibit
spread
cell
concentrationdepend
manner
viral
spread
reduc
cocultur
harbour
plt
per
ml
concentr
close
found
human
blood
figur
inhibit
due
reduc
cell
surviv
determin
annexin
v
stain
data
shown
note
untreat
platelet
larg
maintain
granul
content
black
bar
adept
suppress
activ
thu
degranul
platelet
white
bar
wash
addit
cell
figur
thu
close
cultur
system
platelet
inhibit
spread
concentr
activ
statusdepend
manner
observ
activ
wash
platelet
less
abl
suppress
infect
rel
untreat
platelet
indic
content
platelet
granul
releas
cultur
supernat
upon
activ
might
contain
one
factor
inhibit
address
possibl
incub
tzmbl
indic
cell
supernat
rest
rplt
sup
activ
platelet
aplt
sup
prior
infect
replic
compet
control
cell
treat
pb
pb
contain
trap
measur
atp
level
cultur
show
neither
substanc
use
modul
platelet
activ
platelet
supernat
interf
cell
viabil
addit
file
figur
data
shown
pretreat
indic
cell
pb
trap
supernat
rest
platelet
impact
infect
figur
contrast
supernat
activ
platelet
reduc
infect
approxim
figur
demonstr
factor
releas
upon
platelet
activ
inhibit
infect
next
assess
supernat
activ
platelet
inhibit
infect
stage
host
cell
entri
also
activ
siv
determin
supernat
inhibit
infect
envelopedefect
lentivir
vector
pseudotyp
env
protein
amphotrop
murin
leukemia
viru
mlv
well
gprotein
vesicular
stomat
viru
vsvg
addit
examin
inhibit
authent
rod
none
virus
test
inhibit
trap
figur
supernat
activ
platelet
block
infect
pseudotyp
bear
env
vsvg
although
experi
minor
decreas
vsvgmediat
entri
observ
indic
inhibit
infect
occur
stage
viru
entri
contrast
infect
rod
effici
inhibit
similar
result
obtain
macrophag
tropic
variant
env
figur
addit
file
figur
thu
among
primat
lentivirus
inhibitori
activ
seem
larg
specif
env
final
entri
driven
mlv
env
protein
also
inhibit
figur
addit
file
figur
suggest
mlv
env
might
share
bind
surfac
plateletderiv
inhibitori
factor
altern
protein
might
target
least
two
separ
antivir
activ
releas
platelet
next
test
possibl
antivir
activ
releas
platelet
might
target
certain
coreceptor
tropism
might
specif
certain
strain
howev
analysi
panel
loop
mutant
either
use
coreceptor
infecti
entri
figur
sever
molecular
clone
figur
demonstr
inhibit
platelet
supernat
neither
coreceptor
strain
specif
character
inhibitori
activ
releas
platelet
detail
first
ask
could
inactiv
high
temperatur
inde
incub
platelet
supernat
larg
abrog
antivir
activ
supernat
maintain
room
temperatur
activ
figur
result
compat
proteinac
factor
respons
inhibit
character
factor
auerbach
colleagu
report
chemokin
abund
granul
platelet
inhibit
siv
entri
howev
result
exclus
obtain
purifi
platelet
analys
therefor
investig
might
respons
effici
inhibit
mlv
env
pseudotyp
supernat
activ
platelet
recombin
markedli
inhibit
infect
driven
mlv
env
minor
although
statist
signific
effect
vsvgdepend
entri
figur
thu
exhibit
inhibitori
profil
similar
platelet
supernat
figur
neutral
antibodi
abrog
inhibit
recombin
addit
file
figur
use
investig
contribut
chemokin
antivir
activ
platelet
supernat
incub
platelet
supernat
antibodi
larg
abrog
inhibit
mlv
envbear
pseudotyp
figur
indic
platelet
supernat
mainli
account
antivir
activ
platelet
anucl
fragment
megakaryocyt
central
role
primari
secondari
haemostasi
becom
appreci
howev
platelet
function
beyond
ensur
integr
vasculatur
includ
role
defenc
invad
pathogen
found
activ
platelet
induc
releas
one
antivir
factor
suppress
infect
stage
viral
entri
inhibit
sever
strain
observ
antivir
activ
independ
coreceptor
tropism
target
cell
type
recombin
inhibit
infect
inhibit
platelet
supernat
larg
rescu
neutral
antibodi
indic
major
contribut
inhibit
platelet
result
suggest
platelet
could
constitut
far
unappreci
innat
defenc
infect
well
document
platelet
associ
cell
cultur
infect
patient
previou
result
studi
boukour
colleagu
demonstr
platelet
bind
mainli
via
ctype
lectin
dcsign
bound
virion
infecti
adjac
target
cell
ctype
lectinlik
protein
also
contribut
captur
platelet
captur
effici
reduc
compar
dcsign
present
studi
add
mr
list
ctype
lectin
protein
could
contribut
captur
platelet
potenti
megakaryocyt
although
contribut
mr
interact
platelet
remain
demonstr
find
highlight
platelet
express
sever
lectin
involv
pathogen
recognit
might
thu
modul
pathogen
spread
pathogen
specif
immun
respons
presenc
platelet
infect
cell
cultur
reduc
viral
spread
effici
dosedepend
manner
first
sight
find
counterintuit
consid
previou
find
platelet
captur
transfer
infecti
cell
via
lectin
howev
differ
experiment
condit
chosen
gener
result
platelett
cell
cocultur
infect
low
amount
absenc
wash
step
figur
b
present
manuscript
reflect
physiolog
situat
better
condit
previous
chosen
analys
viral
captur
high
amount
input
viru
remov
unbound
viru
platelet
inhibit
observ
cocultur
experi
maxim
platelet
cell
ratio
use
similar
found
human
blood
suggest
plateletdepend
blockad
might
occur
patient
platelet
granul
contain
hundr
bioactiv
molecul
releas
extracellular
space
upon
platelet
activ
two
find
indic
platelet
granul
contain
activ
releas
upon
activ
larg
respons
inhibit
spread
platelett
cell
cocultur
activ
subsequ
wash
thu
granuledepriv
platelet
inhibit
spread
less
effici
untreat
platelet
supernat
activ
rest
platelet
effici
suppress
infect
scenario
rais
two
immedi
question
platelet
activ
infect
cocultur
cell
natur
antivir
factor
concern
trigger
activ
direct
contact
platelet
could
suffici
activ
previous
demonstr
certain
adenovirus
howev
exposur
platelet
viruslik
particl
bear
env
induc
appreci
platelet
activ
addit
file
figur
addit
file
addit
method
argu
hypothesi
altern
activ
platelet
might
rel
unspecif
could
induc
contact
platelet
cell
tissu
cultur
plastic
cultur
scenario
current
favour
figur
addit
file
figur
initi
attempt
identifi
antivir
factor
releas
platelet
focuss
ligand
coreceptor
ccchemokin
rant
cxcchemokin
respect
chemokin
block
entri
releas
detect
upon
platelet
activ
data
shown
agreement
previou
studi
howev
concentr
previous
shown
block
cellular
entri
addit
neutral
antibodi
direct
rescu
inhibit
evid
downregul
platelet
supernat
obtain
data
shown
indic
plateletderiv
involv
blockad
report
publish
prepar
manuscript
show
chemokin
bind
env
inhibit
entri
contrast
cellular
entri
siv
block
present
high
level
platelet
therefor
focuss
analysi
chemokin
platelet
supernat
recombin
exert
antivir
activ
without
interf
coreceptor
express
addit
file
figur
neutral
larg
prevent
inhibit
platelet
supernat
demonstr
inhibit
infect
activ
platelet
mainli
due
releas
recombin
endogen
platelet
supernat
also
inhibit
mlv
envdriven
host
cell
entri
whether
blockad
mlv
env
also
involv
interact
protein
due
bind
host
cell
factor
requir
mlv
envdepend
entri
remain
determin
releas
platelet
could
impact
dissemin
individu
thu
transmiss
via
sexual
particularli
parenter
rout
frequent
involv
micro
vascular
injuri
result
platelet
activ
releas
might
reduc
transmiss
effici
plateletderiv
might
also
modul
viral
spread
chronic
phase
infect
platelet
isol
blood
patient
report
sever
studi
express
activ
marker
moreov
recent
analysi
demonstr
platelet
infect
individu
reduc
threshold
activ
plasma
patient
activ
platelet
obtain
healthi
donor
thu
activ
statu
platelet
increas
context
infect
potenti
due
proinflammatori
cytokin
invad
bacteria
present
elev
level
patient
known
activ
platelet
consequ
platelet
might
constantli
releas
would
explain
viral
load
platelet
count
found
invers
correl
infect
human
direct
correl
level
viral
load
observ
recent
studi
howev
also
need
note
increas
replic
macrophag
success
viral
entri
cell
suggest
might
impact
viral
spread
via
one
mechan
collect
platelet
neg
regul
spread
activ
statusdepend
manner
releas
might
form
innat
defenc
find
line
observ
platelet
express
immun
cell
lectin
tolllik
receptor
employ
receptor
respond
pathogen
invas
ultim
proof
protect
role
platelet
infect
must
come
anim
model
patient
specif
defect
platelet
function
presenc
platelet
cell
cultur
inhibit
spread
activ
statusdepend
manner
without
elicit
cytotox
effect
inhibit
occur
stage
viru
entri
host
cell
observ
siv
blockad
entri
due
releas
chemokin
activ
platelet
addit
inhibit
cellular
entri
vector
bear
mlv
glycoprotein
antivir
activ
plateletderiv
suggest
platelet
might
play
role
defens
infect
mlv
potenti
pathogen
human
embryon
kidney
cell
cultur
dulbecco
modifi
eagl
medium
dmem
tzmbl
express
secret
alkalin
phosphatas
seap
respect
control
hiv
promot
cultur
describ
previous
peripher
blood
mononuclear
cell
pbmc
isol
whole
blood
ficol
biochrom
gradient
centrifug
stimul
three
day
rpmi
medium
supplement
pha
sigma
uml
roch
thereaft
cell
wash
resuspend
rpmi
medium
supplement
uml
roch
seed
densiti
well
plate
infect
cell
cultur
media
contain
uml
penicillin
streptomycin
fetal
calf
serum
paa
laboratori
cell
cultur
maintain
incub
antimous
antimous
antibodi
bd
bioscienc
antimous
antidcsignfitc
biolegend
anti
lsectin
antibodi
describ
elsewher
neutral
neutral
polyclon
antibodi
axxora
use
recombin
human
purchas
r
system
blood
collect
studi
approv
local
ethic
commiss
ethikkommiss
der
medizinischen
hochschul
hannov
votum
studi
particip
gave
inform
written
consent
particip
venou
blood
collect
monovett
citrat
coagul
tube
sarstedt
first
ml
blood
discard
avoid
isol
platelet
activ
due
needl
stick
injuri
platelet
rich
plasma
prp
isol
remain
blood
within
min
blood
collect
low
speed
centrifug
g
min
platelet
isol
ad
excess
pb
prp
follow
centrifug
g
min
prostaglandin
calbiochem
use
maintain
platelet
rest
state
rplt
platelet
activ
aplt
thrombin
receptor
agonist
peptid
trap
sfllrnp
ana
spec
min
room
temperatur
subsequ
wash
pb
indic
platelet
left
untreat
design
plt
use
experi
avoid
interfer
infect
cell
european
consensu
protocol
flow
cytometr
character
platelet
function
employ
analysi
platelet
flow
cytometri
briefli
wash
platelet
incub
antibodi
min
room
temperatur
sampl
wash
excess
pb
analyz
immedi
flow
cytometri
employ
cytom
beckmanncoult
machin
light
scatter
fluoresc
signal
acquir
use
logarithm
amplif
platelet
identifi
characterist
size
gate
confirm
platelet
specif
monoclon
fluorochromeconjug
antibodi
gener
event
collect
per
gate
data
analyz
fc
express
softwar
de
novo
softwar
plasmid
encod
replicationcompet
rod
envdefect
gprotein
vesicular
stomat
viru
vsvg
envelop
protein
env
amphotrop
murin
leukemia
viru
variant
bear
heterolog
describ
previous
express
plasmid
env
gener
clone
env
gene
plasmid
pcgiresgfp
use
mlui
xbai
restrict
site
ident
sequenc
verifi
autom
sequenc
analysi
molecular
clone
bal
brulav
jrcsf
obtain
nih
aid
research
refer
reagent
program
product
replicationcompet
singl
cycl
report
viru
bear
heterolog
glycoprotein
describ
previous
briefli
cell
capotransfect
plasmid
encod
provir
dna
envdefect
provir
dna
conjunct
express
plasmid
heterolog
glycoprotein
cultur
medium
replac
h
transfect
supernat
harvest
h
post
transfect
supernat
pass
filter
aliquot
store
virus
normal
equal
content
elisa
siacfredrick
advanc
bioscienc
laboratori
compar
infect
use
tzmbl
cell
target
commerci
avail
kit
appli
biosystem
quantif
activ
analyz
impact
platelet
spread
close
cultur
system
wash
platelet
concentr
serial
dilut
concentr
cocultur
cell
pbmc
plate
infect
equal
volum
cellular
supernat
contain
concentr
pgwell
replic
cell
measur
quantif
seapact
cultur
supernat
day
post
infect
employ
commerci
avail
kit
appli
biosystem
quantif
replic
pbmc
amount
releas
cultur
supernat
quantifi
day
day
post
infect
employ
elisa
kit
advanc
bioscienc
laboratori
order
assess
antivir
activ
platelet
supernat
siv
molecular
clone
envdefect
pseudotyp
homolog
heterolog
glycoprotein
variant
normal
compar
content
pgwell
compar
infect
use
infect
tzmbl
cell
seed
densiti
per
well
well
plate
presenc
absenc
supernat
obtain
rest
activ
platelet
medium
chang
h
post
infect
day
post
infect
cultur
lyse
luciferas
activ
lysat
determin
use
commerci
avail
kit
promega
appli
biosystem
heat
inactiv
supernat
activ
platelet
perform
min
determin
antivir
activ
platelet
chemokin
tzmbl
indic
cell
seed
plate
preincub
indic
concentr
min
infect
pseudotyp
bear
env
mlv
env
vsvg
h
post
infect
medium
replac
fresh
cultur
medium
cell
incub
day
thereaft
infect
quantifi
assay
appli
biosystem
order
determin
contribut
antivir
activ
platelet
supernat
supernat
incub
neutral
antibodi
final
concentr
min
incub
rt
viru
ad
platelet
supernat
mix
immedi
transfer
onto
tzmbl
indic
cell
cell
cultur
medium
replac
fresh
medium
h
activ
cell
lysat
measur
h
post
infect
describ
statist
signific
determin
use
student
test
pair
sampl
use
excel
softwar
aid
acquir
immunodefici
syndrom
hiv
human
immunodefici
viru
dcsign
dendrit
cellspecif
intercellular
adhes
nonintegrin
cxc
chemokin
ligand
author
declar
compet
interest
tst
kg
conduct
experi
analyz
data
mk
ak
nrm
conduct
experi
gb
provid
materi
design
experi
jm
perform
experi
analyz
data
sp
conceiv
studi
design
experi
analyz
data
wrote
manuscript
author
read
approv
final
manuscript
